AVADEL PHARMACEUTICALS PLC - SPONSORED ADR (AVDL)

Historical Portfolio Holders from Q4 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q3 2024
1.07M
Holdings value Q3 2024
$14M
Value change Q3 2024
-$83.7M
Grand Portfolio weight change Q3 2024
0%
Number of holders
5
Number of buys Q3 2024
0
Number of sells Q3 2024
-6
Average buys Q3 2024 %
0
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.07M $14M -$83.7M $13.12 5
2024 Q2 7.03M $98.8M -$1.04B $14.06 10
2024 Q1 68.4M $1.16B +$215M $16.89 122
2023 Q4 56.1M $792M +$22.5M $14.12 112
2023 Q3 54.3M $559M +$10.5M $10.30 98
2023 Q2 52M $856M +$74.7M $16.48 99
2023 Q1 48.4M $443M +$138M $9.16 90
2022 Q4 33.5M $239M +$16.1M $7.16 87
2022 Q3 31.4M $157M -$10.6M $5.01 75
2022 Q2 33.7M $82.3M -$28.5M $2.44 79
2022 Q1 35.8M $245M -$689K $6.83 81
2021 Q4 34.9M $282M +$4.3M $8.08 80
2021 Q3 32.1M $314M -$2.36M $9.80 84
2021 Q2 32.6M $219M -$1.41M $6.73 80
2021 Q1 32.6M $294M +$1.57M $9.04 78
2020 Q4 32M $214M +$3.68M $6.68 79
2020 Q3 31.5M $159M -$40.7M $5.04 78
2020 Q2 36.3M $293M +$73.4M $8.08 78
2020 Q1 26.9M $211M +$55.7M $7.94 59
2019 Q4 18.4M $139M +$3.41M $7.55 42
2019 Q3 19.4M $80.6M +$347K $4.16 40
2019 Q2 19.3M $55.8M -$533K $2.89 40
2019 Q1 19.6M $28.2M -$885K $1.44 38
2018 Q4 19.8M $51M -$3.33M $2.58 48
2018 Q3 20.1M $88.4M -$2.84M $4.39 62
2018 Q2 20.6M $126M -$36.2M $6.13 67
2018 Q1 25.9M $189M -$4.9M $7.29 72
2017 Q4 26.4M $216M -$17M $8.20 75
2017 Q3 27.1M $284M -$4.79M $10.50 77
2017 Q2 26.1M $288M +$21.6M $11.03 73
2017 Q1 26.6M $257M +$216M $9.68 67
2016 Q4 4.3M $44.7M +$44.7M $10.39 6